Healthcare Leaders Hub

🏠Home 📰News 📝Blog 🎬Videos Advertise Login

Your trusted source for pharmaceutical news, expert insights, and healthcare innovation.

💼𝕏 👥▶️

Content

📰News
📝Blog
🎬Videos

Company

🏠Home
🏢About Us
📧Contact

© 2026 PharmaVoice. All rights reserved. Empowering healthcare leaders.

Privacy Policy•Terms of Service

Pharma Tech

Immunology specialist Khartis Therapeutics emerges from stealth with $95m

Aug 14, 2026, 10:08 AM

Read Full Article → Immunology specialist Khartis Therapeutics emerges from stealth with $95m

Immunology specialist Khartis Therapeutics emerges from stealth with $95m

Translate article text

Choose a language and wait for the translated text.

Khartis was co-founded two years ago by the team at XinThera, a biotech acquired by Gilead.

Immunology specialist Khartis Therapeutics emerges from stealth with $95m | PharmaVoice